Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes.
Yield of training exchanges between Europe and Sub-Saharan Africa.
Correction: Correlation of Diffusion and Metabolic Alterations in Different Clinical Forms of Multiple Sclerosis.
The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
An introduction with medical applications to functional data analysis.
CUPID: Cannabinoid Use in Progressive Inflammatory brain Disease
R PheWAS: Data Analysis and Plotting Tools for Phenome Wide Association Studies in the R Environment.
Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis.
Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction.
Pain in multiple sclerosis: A systematic review of neuroimaging studies.
[Diffusion-tensor magnetic resonance tomography and tractography in multiple sclerosis: a review].
Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis.
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status.
Assessing possible selection bias in a national voluntary MS longitudinal study in Australia.
Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies.
Moral Distress: Recognition, Diagnosis, and Treatment.
Balancing Early Aggression Against Risk of Progression in Multiple Sclerosis.
Natalizumab-induced hepatic injury: A case report and review of literature.
Evidence for classic complement activity in neuromyelitis optica.
Is walking capacity in subjects with multiple sclerosis primarily related to muscle oxidative capacity or maximal muscle strength? A pilot study.
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity.
Multiple sclerosis: Natalizumab reduces cortical pathology in relapsing-remitting multiple sclerosis.
159 Microsurgical descending tractotomy in cases of intractable trigeminal pain syndromes.
Pulmonary tuberculosis with neuromyelitis optica: an uncommon association of a common disease.
Pages
« first
‹ previous
…
245
246
247
248
249
250
251
252
253
…
next ›
last »